Next big COVID-19 treatment may be manufactured antibodies

Development of monoclonal antibodies to target the virus has been endorsed by leading scientists. Scientists are still working out the exact role of neutralizing antibodies in recovery from COVID-19, but drugmakers are confident that the right antibodies or a combination can alter the course of the disease. Reuters

Other news